ENSEMBLE CAPITAL’S FOURTH QUARTER 2022 INVESTMENT AND MARKET UPDATE
Each quarter, Ensemble Capital hosts a webinar to discuss the current market, economic conditions, and a few of our portfolio holdings. This quarter, the team will present on our investments in Masimo and Paychex.
The event will use a webinar format. Participants will have a chance to ask live questions of the research team during the Q&A portion of the event.
This quarter’s webinar will be held on Monday, January 9 at 1:30 pm (PST)
We’d love for you to join us, which you can do by REGISTERING HERE.
If you’d like to listen to our previously-held quarterly updates, an archive can be FOUND HERE.
We hope to see you there!
For more information about positions owned by Ensemble Capital on behalf of clients as well as additional disclosure information related to this post, please CLICK HERE.
While we do not accept public comments on this blog for compliance reasons, we encourage readers to contact us with their thoughts.
Past performance is no guarantee of future results. All investments in securities carry risks, including the risk of losing one’s entire investment. The opinions expressed within this blog post are as of the date of publication and are provided for informational purposes only. Content will not be updated after publication and should not be considered current after the publication date. All opinions are subject to change without notice and due to changes in the market or economic conditions may not necessarily come to pass. Nothing contained herein should be construed as a comprehensive statement of the matters discussed, considered investment, financial, legal, or tax advice, or a recommendation to buy or sell any securities, and no investment decision should be made based solely on any information provided herein. Links to third party content are included for convenience only, we do not endorse, sponsor, or recommend any of the third parties or their websites and do not guarantee the adequacy of information contained within their websites. Please follow the link above for additional disclosure information.